Translational Science

Testing directly on a diseased human cell is more efficient and more accurate, but ambition is lacking

We ask an expert from Elsevier about the future of digital tech in drug discovery.

The case of Kathleen Folbigg shows how far the field has come, but there are still no medical interventions for sudden infant death syndrome.

Widely-used antimalarial drugs are losing efficacy. What are researchers doing to prevent that?

Cryopreservation should maintain the viability of organs and cell therapies, but the process is riddled with challenges.

The remarkable story of gene therapy drug development during the 1990s and early 2000s.

Pharma must ask itself how it will contribute to the fight against women’s mental health challenges.

AI’s role in pharma operations and process is growing. But does it have the power to transform the industry?

The cell cycle can be used to shut down cancer’s survival mechanisms, but what does it take to turn that knowledge into a medicine?

We speak with Daniel Hornburg from Seer, a biotech company analyzing the proteomes of astronauts.